3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
37
Leiomyosarcoma
12
Liposarcoma
10
Sarcoma, Ewing
4
Neoplasms
4
Liposarcoma, Myxoid
4
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Sarcoma, Alveolar Soft Part
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neurofibrosarcoma
2
Malignant mesenchymal tumor
2
Ichthyosis, X-Linked
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Bone Neoplasms
2
Wilms Tumor
1
Solitary Fibrous Tumors
1
Sarcoma, Endometrial Stromal
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leiomyosarcoma Uterus
1
Hemangioendothelioma
1
Interventions
pazopanib
2
Ifosfamide
2
Doxorubicin
2
selinexor
1
repotrectinib
1
pembrolizumab
1
eribulin
1
Trabectedin
1
Suspensions
1
Sunitinib
1
Proton Therapy
1
Nivolumab
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Histamine H2 Antagonists
1
Fluorodeoxyglucose F18
1
Famotidine
1
FAPI-46
1
Epirubicin
1
Dasatinib
1
Dacarbazine
1
Cisplatin
1
Capsules
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Trabectedin
×
Sarcoma
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled